• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续3年以上的持续性心房颤动与导管消融术后较高的复发率相关。

Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation.

作者信息

Yu Hee Tae, Kim In-Soo, Kim Tae-Hoon, Uhm Jae-Sun, Kim Jong-Youn, Joung Boyoung, Lee Moon-Hyoung, Pak Hui-Nam

机构信息

Division of Cardiology, Yonsei University Health System, Seoul, Republic of Korea.

出版信息

J Cardiovasc Electrophysiol. 2020 Feb;31(2):457-464. doi: 10.1111/jce.14345. Epub 2020 Jan 15.

DOI:10.1111/jce.14345
PMID:31919909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7027787/
Abstract

INSTRUCTION

Longer atrial fibrillation (AF) durations have higher recurrence rates after rhythm control. However, there is limited data on the effect of the AF duration on recurrence after atrial fibrillation catheter ablation (AFCA). In the present study, we investigated the rhythm outcome of AFCA according to the AF duration based on the first electrocardiogram (ECG) diagnosis.

METHODS AND RESULTS

We included 1005 patients with AF (75% male, 59 ± 11 years old) who underwent AFCA and whose first ECG diagnosis time point was evident. The clinical characteristics and rhythm outcomes were compared based on the AF duration (≤3 years, n = 537; >3 years, n = 468) and AF burden (paroxysmal atrial fibrillation [PAF], n = 387; persistent atrial fibrillation [PeAF], n = 618). Longer AF durations were associated with older age (P = .020), larger left atrial size (P = .009) and a higher number of patients with hypertension (P < .001) or PeAF (P < .001). During 24 ± 22 months of follow-up, the postablation clinical recurrence rate was higher in patients with a longer AF duration (logrank P = .002). The AF recurrence rate was significantly higher in PeAF patients with an AF duration >3 years (logrank P = 0.009), but not in subjects with PAF (logrank P = .939). In a multivariate Cox regression analysis, a longer AF duration was significantly associated with a higher clinical recurrence rate after AFCA in PeAF patients (adjusted hazard ratio, 1.06; range, 1.03-0.10; P = 0.001), but not PAF.

CONCLUSION

Although longer AF duration was associated with higher clinical recurrence rates after AFCA, the rate was significant in patients with PeAF lasting >3 years, but not in PAF patients.

摘要

说明

房颤(AF)持续时间越长,节律控制后的复发率越高。然而,关于房颤持续时间对房颤导管消融(AFCA)后复发的影响的数据有限。在本研究中,我们根据首次心电图(ECG)诊断的房颤持续时间,研究了AFCA的节律结果。

方法与结果

我们纳入了1005例接受AFCA且首次心电图诊断时间点明确的房颤患者(75%为男性,年龄59±11岁)。根据房颤持续时间(≤3年,n = 537;>3年,n = 468)和房颤负荷(阵发性房颤[PAF],n = 387;持续性房颤[PeAF],n = 618)比较临床特征和节律结果。较长的房颤持续时间与年龄较大(P = 0.020)、左心房较大(P = 0.009)以及高血压患者(P < 0.001)或PeAF患者(P < 0.001)数量较多相关。在24±22个月的随访期间,房颤持续时间较长的患者消融后临床复发率较高(对数秩检验P = 0.002)。房颤持续时间>3年的PeAF患者房颤复发率显著较高(对数秩检验P = 0.009),但PAF患者中则不然(对数秩检验P = 0.939)。在多因素Cox回归分析中,较长的房颤持续时间与PeAF患者AFCA后较高的临床复发率显著相关(调整后风险比,1.06;范围,1.03 - 0.10;P = 0.001),但与PAF患者无关。

结论

虽然较长的房颤持续时间与AFCA后较高的临床复发率相关,但在持续时间>3年的PeAF患者中该比率显著,而在PAF患者中则不然。

相似文献

1
Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation.持续3年以上的持续性心房颤动与导管消融术后较高的复发率相关。
J Cardiovasc Electrophysiol. 2020 Feb;31(2):457-464. doi: 10.1111/jce.14345. Epub 2020 Jan 15.
2
Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.FIRM 技术消融阵发性和持续性心房颤动的单中心经验。
J Cardiovasc Electrophysiol. 2019 Apr;30(4):493-502. doi: 10.1111/jce.13832. Epub 2019 Jan 8.
3
Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.持续性非永久性房颤的双房线性消融:消融和抗心律失常药物治疗非永久性房颤(SMAN-PAF)试验中的基质改良结果。
Heart Rhythm. 2016 Feb;13(2):399-406. doi: 10.1016/j.hrthm.2015.10.006. Epub 2015 Oct 9.
4
Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study.房颤在非常年轻的成年人中的导管消融:5 年随访研究。
Europace. 2018 Jan 1;20(1):58-64. doi: 10.1093/europace/euw378.
5
Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation.房颤同期外科消融术后长期成功的预测因素
Semin Thorac Cardiovasc Surg. 2017;29(3):294-298. doi: 10.1053/j.semtcvs.2017.08.015. Epub 2017 Aug 25.
6
Association between prolonged P wave duration and left atrial scarring in patients with paroxysmal atrial fibrillation.阵发性心房颤动患者的 P 波持续时间延长与左心房瘢痕形成之间的关系。
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1811-1818. doi: 10.1111/jce.14070. Epub 2019 Jul 23.
7
Targeted ablation of specific electrogram patterns in low-voltage areas after pulmonary vein antral isolation in persistent atrial fibrillation: Termination to an organized rhythm reduces atrial fibrillation recurrence.肺静脉电隔离术后低电压区特定电图模式的靶向消融:终止有组织节律可减少心房颤动复发。
J Cardiovasc Electrophysiol. 2019 Jan;30(1):47-57. doi: 10.1111/jce.13763. Epub 2018 Oct 29.
8
Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation.持续性心房颤动导管消融术后左心房逆向重构与窦性心律维持之间的关联
Heart Vessels. 2020 Feb;35(2):239-245. doi: 10.1007/s00380-019-01475-1. Epub 2019 Jul 25.
9
Left atrial anatomy, atrial fibrillation burden, and P-wave duration-relationships and predictors for single-procedure success after pulmonary vein isolation.左心房解剖结构、心房颤动负荷和 P 波持续时间-肺静脉隔离单次手术成功的关系及预测因素。
Europace. 2018 Feb 1;20(2):271-278. doi: 10.1093/europace/euw376.
10
Efficacy of Left Atrial Voltage-Based Catheter Ablation of Persistent Atrial Fibrillation.基于左心房电压的持续性心房颤动导管消融术的疗效
J Cardiovasc Electrophysiol. 2016 Sep;27(9):1055-63. doi: 10.1111/jce.13019. Epub 2016 Jun 30.

引用本文的文献

1
Beyond Pulmonary Vein Reconnection: Exploring the Dynamic Pathophysiology of Atrial Fibrillation Recurrence After Catheter Ablation.超越肺静脉隔离:探索导管消融术后房颤复发的动态病理生理学
J Clin Med. 2025 Apr 23;14(9):2919. doi: 10.3390/jcm14092919.
2
Evaluating inflammatory status to predict atrial fibrillation recurrence following ablation: The role of systemic immune-inflammation index.评估炎症状态以预测消融术后房颤复发:全身免疫炎症指数的作用
World J Cardiol. 2025 Mar 26;17(3):103074. doi: 10.4330/wjc.v17.i3.103074.
3
Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis.

本文引用的文献

1
Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients With Impaired Cognitive Function.心房颤动导管消融术改善 1 年随访时的认知功能,尤其在认知功能受损的患者中。
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007197. doi: 10.1161/CIRCEP.119.007197. Epub 2019 Jul 1.
2
Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry.心房颤动病史对导管消融结果的影响。欧洲心脏病学会-欧洲心律协会心房颤动消融长期注册研究的结果
Pacing Clin Electrophysiol. 2019 Mar;42(3):313-320. doi: 10.1111/pace.13600. Epub 2019 Jan 22.
3
导管消融术后心房颤动复发的危险因素:一项荟萃分析。
Egypt Heart J. 2025 Jan 13;77(1):9. doi: 10.1186/s43044-025-00605-7.
4
Left Atrial Appendage Closure With Catheter Ablation vs. Ablation Alone on Outcomes of Atrial Fibrillation in Heart Failure With Reduced Ejection Fraction: A Propensity Score-Matched Analysis.导管消融联合左心耳封堵术与单纯消融术对射血分数降低的心力衰竭患者房颤结局的影响:一项倾向评分匹配分析
Cureus. 2024 Nov 27;16(11):e74577. doi: 10.7759/cureus.74577. eCollection 2024 Nov.
5
Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation.心房颤动类型和慢性肾脏病是射频消融术后心房颤动复发的独立预测因素。
Ther Clin Risk Manag. 2024 Dec 3;20:817-828. doi: 10.2147/TCRM.S492265. eCollection 2024.
6
The association between left atrial appendage emptying velocity and atrial fibrillation recurrence after radiofrequency catheter ablation in patients with early persistent atrial fibrillation.早期持续性心房颤动患者射频导管消融术后左心耳排空速度与心房颤动复发的关系。
BMC Cardiovasc Disord. 2024 Oct 1;24(1):529. doi: 10.1186/s12872-024-04215-0.
7
Invasive strategies for rhythm control of atrial fibrillation: a narrative review.心房颤动节律控制的侵入性策略:一项叙述性综述。
J Yeungnam Med Sci. 2024 Oct;41(4):279-287. doi: 10.12701/jyms.2024.00703. Epub 2024 Sep 20.
8
Effects of antiarrhythmic drug responsiveness and diagnosis-to-ablation time on outcomes after catheter ablation for persistent atrial fibrillation.抗心律失常药物反应性及诊断至消融时间对持续性心房颤动导管消融术后结局的影响
J Arrhythm. 2024 Jul 2;40(4):867-878. doi: 10.1002/joa3.13104. eCollection 2024 Aug.
9
Relationship between anatomical characteristics of pulmonary veins and atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review and meta-analysis.肺静脉解剖特征与射频导管消融术后房颤复发的关系:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2023 Sep 19;10:1235433. doi: 10.3389/fcvm.2023.1235433. eCollection 2023.
10
Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.开发并验证一种新的预测模型,用于预测在第一次射频导管消融治疗中使用尼非卡兰的持续性心房颤动患者的心房颤动复发风险。
Cardiovasc Drugs Ther. 2023 Dec;37(6):1117-1129. doi: 10.1007/s10557-022-07353-9. Epub 2022 Jun 22.
Trends and Outcome of Catheter Ablation of Atrial Fibrillation Over 9 Years - Focus on Empirical Extra-Pulmonary Vein Ablation.
9 年房颤导管消融的趋势和结果 - 关注经验性肺静脉外消融。
Circ J. 2019 Jan 25;83(2):304-312. doi: 10.1253/circj.CJ-18-0928. Epub 2019 Jan 9.
4
When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.非维生素 K 拮抗剂口服抗凝剂在房颤导管消融前何时停药合适?一项多中心前瞻性随机研究。
Eur Heart J. 2019 May 14;40(19):1531-1537. doi: 10.1093/eurheartj/ehy870.
5
Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.心房颤动负担、进展与死亡风险:心脏植入式电子设备患者的病例交叉分析。
Europace. 2019 Mar 1;21(3):404-413. doi: 10.1093/europace/euy222.
6
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.代谢综合征与心房颤动患者非血栓栓塞性不良心脏结局的关系。
Eur Heart J. 2018 Dec 1;39(45):4030-4039. doi: 10.1093/eurheartj/ehy446.
7
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population.全国范围内非瓣膜性心房颤动的发病率、患病率和不良结局的 10 年全国健康保险数据涵盖了全体韩国人口。
Am Heart J. 2018 Aug;202:20-26. doi: 10.1016/j.ahj.2018.04.017. Epub 2018 May 1.
8
Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 Studies.肥胖与新发、术后及消融术后房颤风险:对51项研究中626,603人的荟萃分析
JACC Clin Electrophysiol. 2015 Jun;1(3):139-152. doi: 10.1016/j.jacep.2015.04.004. Epub 2015 Apr 20.
9
A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation.阵发性房颤进展为持续性房颤的系统评价:导管消融术效果的新见解
JACC Clin Electrophysiol. 2015 Jun;1(3):105-115. doi: 10.1016/j.jacep.2015.04.010. Epub 2015 May 13.
10
Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.用于治疗心房颤动患者的消融术或抗心律失常药物后的中风和心血管事件
Am J Cardiol. 2018 May 15;121(10):1192-1199. doi: 10.1016/j.amjcard.2018.01.043. Epub 2018 Feb 12.